Literature DB >> 22869179

Cisplatin-induced primordial follicle oocyte killing and loss of fertility are not prevented by imatinib.

Jeffrey B Kerr, Karla J Hutt, Michele Cook, Terence P Speed, Andreas Strasser, Jock K Findlay, Clare L Scott.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22869179      PMCID： PMC3517916          DOI： 10.1038/nm.2889

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  12 in total

1.  Methods for quantifying follicular numbers within the mouse ovary.

Authors:  M Myers; K L Britt; N G M Wreford; F J P Ebling; J B Kerr
Journal:  Reproduction       Date:  2004-05       Impact factor: 3.906

2.  p63 protects the female germ line during meiotic arrest.

Authors:  Eun-Kyung Suh; Annie Yang; Arminja Kettenbach; Casimir Bamberger; Ala H Michaelis; Zhou Zhu; Julia A Elvin; Roderick T Bronson; Christopher P Crum; Frank McKeon
Journal:  Nature       Date:  2006-11-22       Impact factor: 49.962

Review 3.  Neoadjuvant and adjuvant imatinib treatment in gastrointestinal stromal tumor: current status and recent developments.

Authors:  David Reynoso; Jonathan C Trent
Journal:  Curr Opin Oncol       Date:  2010-07       Impact factor: 3.645

4.  STI571 inactivation of the gastrointestinal stromal tumor c-KIT oncoprotein: biological and clinical implications.

Authors:  D A Tuveson; N A Willis; T Jacks; J D Griffin; S Singer; C D Fletcher; J A Fletcher; G D Demetri
Journal:  Oncogene       Date:  2001-08-16       Impact factor: 9.867

5.  The selective tyrosine kinase inhibitor STI571 inhibits small cell lung cancer growth.

Authors:  G W Krystal; S Honsawek; J Litz; E Buchdunger
Journal:  Clin Cancer Res       Date:  2000-08       Impact factor: 12.531

6.  Kit ligand and c-Kit are expressed during early human ovarian follicular development and their interaction is required for the survival of follicles in long-term culture.

Authors:  Inger B Carlsson; Mika P E Laitinen; Jennifer E Scott; Henna Louhio; Louiza Velentzis; Timo Tuuri; Johanna Aaltonen; Olli Ritvos; Robert M L Winston; Outi Hovatta
Journal:  Reproduction       Date:  2006-04       Impact factor: 3.906

7.  p63 null mutation protects mouse oocytes from radio-induced apoptosis.

Authors:  Gabriel Livera; Béatrice Petre-Lazar; Marie-Justine Guerquin; Emilie Trautmann; Hervé Coffigny; René Habert
Journal:  Reproduction       Date:  2008-01       Impact factor: 3.906

Review 8.  Kit ligand and c-Kit have diverse roles during mammalian oogenesis and folliculogenesis.

Authors:  K J Hutt; E A McLaughlin; M K Holland
Journal:  Mol Hum Reprod       Date:  2006-02-15       Impact factor: 4.025

9.  The p63/p73 network mediates chemosensitivity to cisplatin in a biologically defined subset of primary breast cancers.

Authors:  Chee-Onn Leong; Nick Vidnovic; Maurice Phillip DeYoung; Dennis Sgroi; Leif W Ellisen
Journal:  J Clin Invest       Date:  2007-04-19       Impact factor: 14.808

10.  Quantification of healthy follicles in the neonatal and adult mouse ovary: evidence for maintenance of primordial follicle supply.

Authors:  J B Kerr; R Duckett; M Myers; K L Britt; T Mladenovska; J K Findlay
Journal:  Reproduction       Date:  2006-07       Impact factor: 3.906
View more
  35 in total

Review 1.  Can Some Anticancer Treatments Preserve the Ovarian Reserve?

Authors:  Nicolas Vallet; Nicolas Boissel; Elisabeth Elefant; Florian Chevillon; Hélène Pasquer; Charlotte Calvo; Nathalie Dhedin; Catherine Poirot
Journal:  Oncologist       Date:  2021-01-29

2.  How to best preserve oocytes in female cancer patients exposed to DNA damage inducing therapeutics.

Authors:  K Hutt; J B Kerr; C L Scott; J K Findlay; A Strasser
Journal:  Cell Death Differ       Date:  2013-08       Impact factor: 15.828

3.  Inhibitors of apoptosis protect the ovarian reserve from cyclophosphamide.

Authors:  Yi Luan; Maxwell E Edmonds; Teresa K Woodruff; So-Youn Kim
Journal:  J Endocrinol       Date:  2019-02-01       Impact factor: 4.286

4.  Transient inhibition of p53 homologs protects ovarian function from two distinct apoptotic pathways triggered by anticancer therapies.

Authors:  So-Youn Kim; Devi M Nair; Megan Romero; Vanida A Serna; Anthony J Koleske; Teresa K Woodruff; Takeshi Kurita
Journal:  Cell Death Differ       Date:  2018-07-09       Impact factor: 15.828

Review 5.  Challenges and Potential for Ovarian Preservation with SERMs.

Authors:  Alison Y Ting; Brian K Petroff
Journal:  Biol Reprod       Date:  2015-03-25       Impact factor: 4.285

6.  Reply to: Cisplatin-induced primordial follicle oocyte killing and loss of fertility are not prevented by imatinib.

Authors:  Emiliano Maiani; Claudia Di Bartolomeo; Francesca G Klinger; Stefano M Cannata; Sergio Bernardini; Sebastien Chateauvieux; Fabienne Mack; Maurizio Mattei; Massimo De Felici; Marc Diederich; Gianni Cesareni; Stefania Gonfloni
Journal:  Nat Med       Date:  2012-08       Impact factor: 53.440

Review 7.  Chemotherapy-induced damage to ovary: mechanisms and clinical impact.

Authors:  Giuliano Bedoschi; Paula Andrea Navarro; Kutluk Oktay
Journal:  Future Oncol       Date:  2016-07-12       Impact factor: 3.404

8.  CHK2 sets the stage for CK1 in oocyte quality control.

Authors:  Sebastian Kehrloesser; Marcel Tuppi; Volker Dötsch
Journal:  Cell Death Differ       Date:  2018-06       Impact factor: 15.828

9.  Continuous treatment with cisplatin induces the oocyte death of primordial follicles without activation.

Authors:  Maya Eldani; Yi Luan; Pauline C Xu; Tom Bargar; So-Youn Kim
Journal:  FASEB J       Date:  2020-08-23       Impact factor: 5.191

10.  Rescue of platinum-damaged oocytes from programmed cell death through inactivation of the p53 family signaling network.

Authors:  S-Y Kim; M H Cordeiro; V A Serna; K Ebbert; L M Butler; S Sinha; A A Mills; T K Woodruff; T Kurita
Journal:  Cell Death Differ       Date:  2013-04-19       Impact factor: 15.828
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.